Where Tech Meets Bio
Latest News
Trogenix Ltd has launched its Odysseus platform, leveraging Synthetic Super-Enhancer (SSE) technology to advance precision viral immunotherapy for aggressive cancers.
Read More
Novartis Expands Radiopharmaceutical Portfolio with $745M Deal with Ratio Therapeutics
Novartis has struck a licensing agreement with Boston-based biotech Ratio Therapeutics, securing global rights to a promising cancer candidate targeting somatostatin receptor 2 (SSTR2). The …
Read More
Medable Adds Generative AI to Simplify and Speed Up Clinical Trials
Medable Inc. has introduced generative AI capabilities to its Medable Studio platform to streamline and accelerate digital and decentralized clinical trial workflows. The new feature, …
Read More
Latest News
40,000 NHS Healthcare Workers to Get AI Tool That Cuts Admin Time by 80%
Immunai and Teva Collaborate to Advance Clinical Trials in Oncology and Immunology
Enveda Advances AI-Discovered, Nature-Derived Drug ENV-294 to Phase 1 Trials
Genesis Therapeutics Collaborates with NVIDIA and Secures Additional NVentures Funding to Accelerate AI-Driven Drug Discovery
Recursion Unveils OpenPhenom-S/16: A Foundation Model for Microscopy Data
Schrödinger and Novartis Forge Partnership to Scale Computational Drug Discovery
Latest Insights
by Andrii Buvailo, PhD
Scientists Found a New Epigenetic Factor Preventing Inherited Diseases
Researchers at the University of Queensland have identified a crucial mechanism in mitochondrial DNA (mtDNA) that helps regulate the inheritance of disease-causing mutations. This mechanism …
Read More
by Illia Petrov
The Promise of Chatbots in Clinical Trials
In the rapidly changing field of clinical trials, chatbots are becoming valuable tools for data analysis. These AI-driven conversational agents streamline data collection, boost patient …
Read More
Survey Highlights Critical Need for AI Adoption in Regulatory Affairs Amid Unsustainable Workloads
by Roman Kasianov
What will be the key trends in AI innovation in the Pharmaceutical Industry in 2025?
by Marina Hickson
Cautious Optimism in 2024 for Healthcare M&A
by Merlin Piscitelli
AI Is Key to Democratizing Drug Discovery
by Andrey Doronichev
Key Trends in Aging Research: Where Are We Now?
by Andrii Buvailo, PhD
Global Pharma R&D Investments Surpass $276 Billion Annually, Exceeding Previous Estimates
by Roman Kasianov
The Promise of Chatbots in Clinical Trials
by Illia Petrov
Even 10 Minutes Matter in Cancer Research
by Andrii Buvailo, PhD
From Our Partners
Sponsored by
Syntekabio
How to Discover a Preclinical Drug Candidate in Two Years
Sponsored by
RECEPTOR.AI
This AI Startup Joins Forces With NVIDIA's BioNeMo to Boost Drug Discovery
Sponsored by
Lantern Pharma
AI Breaches the Barrier Towards Better CNS Drug Discovery
Sponsored by
Trialize
Unlocking Interoperability with AI: How This Company is Building a New Framework for Clinical Trials
Partner Events

BIOCHINA 2025
Event Date: March 13, 2025 - March 15, 2025
Location: China (Suzhou International Expo Center)
Website: Link
Promo Code: biopharmatrend (valid till 2024-10-31)
Read more ›››

Global Clinical Trials Connect 2025
Promo Code: GCTC10 (valid till 2025-05-28)
Read more ›››

London Biotechnology Show 2025
Event Date: June 18, 2025 - June 19, 2025
Location: United Kingdom (Hall N7 & N8 Bett Global, Excel London, Royal Victoria Dock, 1 Western Gateway, London, UK, England, GB, E16 1XL)
Website: Link
Promo Code: 4CPHAK
Read more ›››
Case Studies
Sponsored by
RECEPTOR.AI
Busting the PoseBusters v3: AI Docking Software ArtiDock Beats Industry’s State of the Art in Speed and Accuracy
Sponsored by
Cyclica
Cyclica's Chemical Probes for DCAF1
Sponsored by
Science Exchange
How Astellas Pharma Achieves R&D Operational Excellence with Science Exchange
Sponsored by
Roivant Sciences
QUAISAR Computational Platform for Designing Targeted Protein Degraders
Sponsored by
Bioz
Bioz Badges — Advanced Data-Widgets for Confident E-commerce
Sponsored by
Celeris Therapeutics
Application of AI-driven Xanthos Platform for Designing Protein Degraders
Sponsored by
Kymera Therapeutics
Identifying High Impact Tissue Sparing E3 Ligases and Their Binders
Sponsored by
Trialize
Revolutionizing Clinical Trials: How AI and Automation Reduced Study Build Time from Months to Days
Interviews
[Interview] How D-Wave Brings Quantum Computing Into Biology
Pioneering the Largest Foundation Model to Transform RNA Research: An Interview with Brendan Frey
[Interview] This Vancouver-based Startup Plans To Boost Drug Design With AI
[Interview] A Company on the Cutting Edge of COVID-19 Vaccine Development
Most Read
AI Drug Discovery: Key Trends and Developments in Pharmaceutical Industry
7 Promising RNA Biotech Companies To Watch in 2024
Maturing Pharma 4.0: How Digital Transformation Continues To Reshape Pharmaceuticals
14 Companies Using Quantum Theory To Accelerate Drug Discovery (Including 2 Going Public)